Trade Talis Biomedical Corporation - TLIS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.13 |
| Open | 4.15 |
| 1-Year Change | -33.28% |
| Day's Range | 3.95 - 4.38 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Aug 30, 2024 | 4.36 | 0.21 | 5.06% | 4.15 | 4.38 | 3.94 |
| Aug 29, 2024 | 4.13 | 0.06 | 1.47% | 4.07 | 4.38 | 4.06 |
| Aug 28, 2024 | 3.98 | 0.20 | 5.29% | 3.78 | 3.98 | 3.78 |
| Aug 27, 2024 | 3.83 | -0.09 | -2.30% | 3.92 | 3.92 | 3.72 |
| Aug 26, 2024 | 3.98 | 0.30 | 8.15% | 3.68 | 3.98 | 3.60 |
| Aug 23, 2024 | 4.36 | 0.32 | 7.92% | 4.04 | 4.38 | 4.04 |
| Aug 22, 2024 | 4.15 | -0.14 | -3.26% | 4.29 | 4.55 | 4.15 |
| Aug 21, 2024 | 4.26 | 0.13 | 3.15% | 4.13 | 4.33 | 4.13 |
| Aug 20, 2024 | 4.07 | 0.01 | 0.25% | 4.06 | 4.29 | 4.03 |
| Aug 19, 2024 | 4.39 | 0.00 | 0.00% | 4.39 | 4.43 | 4.28 |
| Aug 16, 2024 | 4.33 | 0.44 | 11.31% | 3.89 | 4.33 | 3.89 |
| Aug 15, 2024 | 4.07 | -0.01 | -0.25% | 4.08 | 4.13 | 3.99 |
| Aug 14, 2024 | 3.99 | 0.02 | 0.50% | 3.97 | 4.13 | 3.78 |
| Aug 13, 2024 | 4.03 | 0.19 | 4.95% | 3.84 | 4.03 | 3.84 |
| Aug 12, 2024 | 3.89 | 0.14 | 3.73% | 3.75 | 4.03 | 3.75 |
| Aug 9, 2024 | 3.73 | -0.22 | -5.57% | 3.95 | 4.25 | 3.70 |
| Aug 8, 2024 | 4.18 | -0.20 | -4.57% | 4.38 | 4.39 | 3.95 |
| Aug 7, 2024 | 4.53 | 0.05 | 1.12% | 4.48 | 4.94 | 4.10 |
| Aug 6, 2024 | 8.97 | 0.17 | 1.93% | 8.80 | 9.03 | 8.48 |
| Aug 5, 2024 | 8.68 | 0.15 | 1.76% | 8.53 | 8.97 | 8.38 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Talis Biomedical Corporation Company profile
About Talis Biomedical Corp
Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Talis Biomedical Corp revenues decreased 25% to $8.2M. Net loss increased from $91.1M to $192M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$3.88 to -$7.30.
| Industry: | Biotechnology & Medical Research (NEC) |
1100 Island Drive
Suite 101
REDWOOD CITY
CALIFORNIA 94065
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com